• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.血清癌胚抗原在结直肠癌手术前后检测中的作用。
World J Gastroenterol. 2012 May 7;18(17):2121-6. doi: 10.3748/wjg.v18.i17.2121.
2
Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.术前血清癌胚抗原水平作为结直肠癌根治性切除术后复发的预测因素。
Ann Surg Oncol. 2008 Dec;15(12):3433-9. doi: 10.1245/s10434-008-0168-8. Epub 2008 Oct 10.
3
Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.癌胚抗原和糖类抗原19-9对IV期结直肠癌患者R0切除术后的预后影响
J Surg Res. 2016 Oct;205(2):384-392. doi: 10.1016/j.jss.2016.06.078. Epub 2016 Jul 4.
4
Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.根治性切除术后 I-III 期结直肠癌患者术前癌胚抗原作为预后不良因素的倾向评分匹配分析。
Ann Surg Oncol. 2019 Jun;26(6):1685-1694. doi: 10.1245/s10434-019-07184-3. Epub 2019 Mar 26.
5
Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.治疗后监测检测强度与结直肠癌患者复发检测的关系。
JAMA. 2018 May 22;319(20):2104-2115. doi: 10.1001/jama.2018.5816.
6
Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.血清癌胚抗原预测结直肠癌患者随访中的复发。
Int J Biol Markers. 2019 Mar;34(1):60-68. doi: 10.1177/1724600818820679. Epub 2019 Mar 11.
7
The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.FDG-PET/CT 作为一种有效工具,可用于检测复发性结直肠癌,而与血清 CEA 水平无关。
Ann Nucl Med. 2012 Aug;26(7):551-8. doi: 10.1007/s12149-012-0609-0. Epub 2012 May 30.
8
Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.根治性手术后血清癌胚抗原水平升高是II-III期结直肠癌的预后生物标志物。
Eur J Surg Oncol. 2021 Nov;47(11):2880-2887. doi: 10.1016/j.ejso.2021.05.041. Epub 2021 Jun 2.
9
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.组织和血清癌胚抗原在Ⅰ期至Ⅲ期结直肠癌中的作用——一项回顾性队列研究。
Cancer Med. 2018 Nov;7(11):5327-5338. doi: 10.1002/cam4.1814. Epub 2018 Oct 9.
10
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.术前血清癌胚抗原、白蛋白和年龄在预测接受手术治疗的结直肠癌患者的生存率方面对国际抗癌联盟(UICC)分期系统起到补充作用。
BMC Cancer. 2009 Aug 20;9:288. doi: 10.1186/1471-2407-9-288.

引用本文的文献

1
Is Colonoscopy Alone Adequate for Surveillance in Stage I Colorectal Cancer?单纯结肠镜检查对I期结直肠癌进行监测是否足够?
Cancer Res Treat. 2025 Apr;57(2):507-518. doi: 10.4143/crt.2024.526. Epub 2024 Oct 4.
2
Identification and Validation of Biomarkers to Predict Early Diagnosis of Inflammatory Bowel Disease and Its Progression to Colorectal Cancer.用于预测炎症性肠病早期诊断及其进展为结直肠癌的生物标志物的鉴定与验证
Biochem Genet. 2024 Sep 26. doi: 10.1007/s10528-024-10917-z.
3
Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers.近年来循环核酸在结直肠癌诊断和治疗中的应用技术。
Int J Mol Sci. 2024 Aug 9;25(16):8703. doi: 10.3390/ijms25168703.
4
MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients.miR-193a-3p 作为一种有价值的生物标志物,可用于区分结直肠癌和结直肠腺瘤患者。
Int J Mol Sci. 2024 Jul 26;25(15):8156. doi: 10.3390/ijms25158156.
5
Association of Clinicopathological Factors With MMP13 (rs2252070) Gene Polymorphism in Swedish Patients With Colorectal Cancer.瑞典结直肠癌患者临床病理因素与 MMP13(rs2252070)基因多态性的相关性研究。
In Vivo. 2024 Jul-Aug;38(4):1775-1782. doi: 10.21873/invivo.13628.
6
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients.辅助化疗对直肠癌病理完全缓解后生存的影响:31558 例患者的荟萃分析。
Int J Colorectal Dis. 2024 Jun 24;39(1):96. doi: 10.1007/s00384-024-04668-x.
7
Tumor biomarkers in evaluating the severity and prognosis of idiopathic pulmonary arterial hypertension: A comprehensive analysis.评估特发性肺动脉高压严重程度和预后的肿瘤标志物:综合分析。
Clin Transl Sci. 2024 Mar;17(3):e13751. doi: 10.1111/cts.13751.
8
Predictive modeling algorithms for liver metastasis in colorectal cancer: A systematic review of the current literature.结直肠癌肝转移的预测建模算法:当前文献的系统评价
Ann Hepatobiliary Pancreat Surg. 2024 Feb 29;28(1):14-24. doi: 10.14701/ahbps.23-078. Epub 2023 Dec 22.
9
Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta-analysis.利用循环肿瘤 DNA 进行局部晚期直肠癌的治疗分层和预后评估:系统评价和荟萃分析。
Cancer Med. 2023 Sep;12(17):17934-17944. doi: 10.1002/cam4.6434. Epub 2023 Aug 8.
10
Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level.癌胚抗原(CEA)术前水平对结直肠癌复发检测的诊断准确性。
J Gastrointest Surg. 2023 Aug;27(8):1694-1701. doi: 10.1007/s11605-023-05761-2. Epub 2023 Jul 5.

本文引用的文献

1
C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management.结直肠癌 C 期:癌胚抗原生物标志物在分期、预后和治疗中的意义。
J Natl Cancer Inst. 2011 Apr 20;103(8):689-97. doi: 10.1093/jnci/djr078. Epub 2011 Mar 18.
2
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series.IV 期结直肠癌患者的发病、治疗和生存趋势:一项基于人群的系列研究。
Colorectal Dis. 2012 Jan;14(1):56-61. doi: 10.1111/j.1463-1318.2010.02539.x.
3
Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection.结直肠癌患者根治性切除术后异时性肝转移的危险因素。
World J Surg. 2011 Feb;35(2):424-9. doi: 10.1007/s00268-010-0881-x.
4
Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers.癌胚抗原与 TGF-β 受体相互作用并抑制结直肠癌中的 TGF-β 信号传导。
Cancer Res. 2010 Oct 15;70(20):8159-68. doi: 10.1158/0008-5472.CAN-10-1073. Epub 2010 Oct 1.
5
Tumor markers in clinical practice: General principles and guidelines.临床实践中的肿瘤标志物:一般原则与指南
Indian J Med Paediatr Oncol. 2009 Jan;30(1):1-8. doi: 10.4103/0971-5851.56328.
6
Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.CEA 和 CA19-9 在结直肠癌术后随访中的临床意义。
Ann Surg Oncol. 2010 Sep;17(9):2349-56. doi: 10.1245/s10434-010-1004-5. Epub 2010 Mar 9.
7
Diagnostic value of serum tumor markers in asymptomatic individuals.血清肿瘤标志物在无症状个体中的诊断价值。
J BUON. 2009 Oct-Dec;14(4):707-10.
8
Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.术前癌胚抗原水平是潜在可治愈结肠癌的独立预后因素。
J Surg Oncol. 2010 Apr 1;101(5):396-400. doi: 10.1002/jso.21495.
9
Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.结直肠癌根治术后血清癌胚抗原监测:术前水平的临床意义。
Ann Surg Oncol. 2009 Nov;16(11):3087-93. doi: 10.1245/s10434-009-0625-z. Epub 2009 Jul 23.
10
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

血清癌胚抗原在结直肠癌手术前后检测中的作用。

Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.

机构信息

Department of Gastroenterology, South Building, Chinese People's Liberation Army General Hospital, Beijing 100853, China.

出版信息

World J Gastroenterol. 2012 May 7;18(17):2121-6. doi: 10.3748/wjg.v18.i17.2121.

DOI:10.3748/wjg.v18.i17.2121
PMID:22563201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3342612/
Abstract

AIM

To determine whether serum levels of carcinoembryonic antigen (CEA) correlate with the presence of primary colorectal cancer (CRC), and/or recurrent CRC following radical resection.

METHODS

A total of 413 patients with CRC underwent radical surgery between January 1998 and December 2002 in our department and were enrolled in this study. The median follow-up period was 69 mo (range, 3-118 mo), and CRC recurrence was experienced by 90/413 (21.8%) patients. Serum levels of CEA were assayed preoperatively, and using a cutoff value of 5 ng/mL, patients were divided into two groups, those with normal serum CEA levels (e.g., ≤ 5 ng/mL) and those with elevated CEA levels (> 5 ng/mL).

RESULTS

The overall sensitivity of CEA for the detection of primary CRC was 37.0%. The sensitivity of CEA according to stage, was 21.4%, 38.9%, and 41.7% for stages I-III, respectively. Moreover, for stage II and stage III cases, the 5-year disease-free survival rates were reduced for patients with elevated preoperative serum CEA levels (P < 0.05). The overall sensitivity of CEA for detecting recurrent CRC was 54.4%, and sensitivity rates of 36.6%, 66.7%, and 75.0% were associated with cases of local recurrence, single metastasis, and multiple metastases, respectively. In patients with normal serum levels of CEA preoperatively, the sensitivity of CEA for detecting recurrence was reduced compared with patients having a history of elevated CEA prior to radical resection (32.6% vs 77.3%, respectively, P < 0.05).

CONCLUSION

CRC patients with normal serum CEA levels prior to resection maintained these levels during CRC recurrence, especially in cases of local recurrence vs cases of metastasis.

摘要

目的

确定癌胚抗原(CEA)血清水平是否与原发性结直肠癌(CRC)的存在以及根治性切除术后CRC 的复发相关。

方法

本研究共纳入 1998 年 1 月至 2002 年 12 月期间在我院接受根治性手术的 413 例 CRC 患者。中位随访时间为 69 个月(范围,3-118 个月),90/413(21.8%)例患者出现 CRC 复发。术前检测 CEA 血清水平,以 5ng/mL 为截断值,将患者分为两组,即 CEA 血清水平正常(即≤5ng/mL)和 CEA 血清水平升高(即>5ng/mL)。

结果

CEA 对原发性 CRC 的总体检测敏感性为 37.0%。根据分期,CEA 的敏感性分别为Ⅰ-Ⅲ期的 21.4%、38.9%和 41.7%。此外,对于Ⅱ期和Ⅲ期病例,术前 CEA 血清水平升高的患者 5 年无病生存率降低(P<0.05)。CEA 对检测复发性 CRC 的总体敏感性为 54.4%,局部复发、单发转移和多发转移的敏感性分别为 36.6%、66.7%和 75.0%。术前 CEA 血清水平正常的患者,其 CEA 对复发的检测敏感性低于根治性切除术前 CEA 水平升高的患者(分别为 32.6%和 77.3%,P<0.05)。

结论

CRC 患者根治性切除术前 CEA 血清水平正常者,在 CRC 复发时仍保持此水平,尤其是在局部复发与转移病例中。